Penumbra (NYSE:PEN) yesterday reported third-quarter results that topped the consensus forecast on Wall Street and raised its sales outlook for the rest of the year, despite a nearly 100% profit slide. The Alameda, Calif.-based medical device company posted profits of $238,000, or 1¢ per share, on sales of $83.9 million for the three months ended […]
MassDevice Earnings Roundup
Nevro shares fall as Q3 losses rise
Shares in Nevro (NYSE:NVRO) fell today after the medical device maker posted third quarter earnings that saw losses grow over 50%. The Redwood City, Calif.-based company posted losses of $6.2 million, or 21¢ per share, on sales of $82.3 million for the 3 months ended September 30, seeing losses grow 60.3% while sales grew 35% compared […]
Mazor Robotics crushes expectations with Q3 results
Mazor Robotics (NSDQ:MZOR) today reported third-quarter results that blew past the consensus forecast on Wall Street, more than doubling sales and paring its losses by more than 30%. The Caesarea, Israel-based robot-assisted surgery company posted losses of -$3.7 million, or -7¢ per share, on sales of $17.2 million for the three months ended Sept. 30, cutting […]
Haemonetics to cut 11% of workforce
Haemonetics (NYSE:HAE) said today that it plans to cut roughly 11% of its global workforce as it looks to pare $80 million from its annual cash burn by the end of fiscal 2020. The Braintree, Mass.-based blood management company said it plans to eliminate 350 positions by the end of its fiscal year in April. The company reported […]
Henry Schein shares fall on Q3 EPS miss
Shares in Henry Schein (NSDQ:HSIC) have fallen today after the company posted third quarter earnings which beat sales but missed earning per share expectations on Wall Street. The Melville, N.Y.-based company posted profits of $138 million, or 87¢ per share, on sales of $3.2 billion for the 3 months ended September 30, seeing the bottom-line grow […]
Mylan misses sales, earnings estimate in Q3
Shares in Mylan (NSDQ:MYL) remained steady today after the pharmaceutical company missed expectations on Wall Street with its third quarter results. The Canonsburg, Penn.-based company posted profits of $88.3 million, or 16¢ per share, on sales of $2.99 billion for the 3 months ended Sept. 30, for bottom-line growth of 172% on sales loss of -2% compared with the […]
Cardinal Health logs fiscal Q1 sales miss, earnings beat, announces CEO succession
Cardinal Health (NYSE:CAH) today saw its fiscal first-quarter profits plunge on sales growth of nearly 2% and announced its plans for a CEO succession. Dublin, Ohio-based Cardinal posted profits of $115 million, or 36¢ per share, on sales of $32.64 million for the three months ended Sept. 30, for a bottom-line decrease of -62.8% on sales […]
Dentsply Sirona shares up on Q3 beat
Shares in Dentsply Sirona (NSDQ:XRAY) rose today after the medical device maker beat expectations on Wall Street with its 3rd quarter earnings release. The York, Penn.-based company posted profits of $90.5 million, or 39¢ per share, on sales of $1 billion for the 3 months ended September 30, seeing its bottom line shrink by 2% while its […]
Masimo crushes the Q3 earnings forecast, raises outlook
Masimo (NSDQ:MASI) this week reported third-quarter results that crushed the consensus earnings forecast and raised its sales and earnings outlook for the rest of the year, but share prices still fell on missed sales expectations. Irvine, Calif.-based Masimo posted profits of $39.2 million, or 70¢ per share, on sales of $181.3 million for the three months […]
ConMed ticks up on Street-beating Q3 results
ConMed (NSDQ:CNMD) shares ticked up today after the medical device company yesterday reported third-quarter results that topped Wall Street’s forecast and announced the retirement of its financial chief. Utica, N.Y.-based ConMed posted profits of $7.2 million, or 26¢ per share, on sales of $190.1 million for the three months ended Sept. 30, for a -1.9% […]
Hill-Rom’s Q4, 2017 earnings top estimates, sales miss
Hill-Rom Holdings (NYSE:HRC) shares came under pressure this morning after the medical device company reported fourth-quarter and full-year results that beat Wall Street’s consensus on earnings but missed its sales forecast. Chicago-based Hill-Rom posted profits of $69.4 million, or $1.03 per share, on sales of $643.5 million for the three months ended Sept. 30, for […]